Patients’ Induced Pluripotent Stem Cells to Model Drug Induced Adverse Events: A Role in Predicting Thiopurine Induced Pancreatitis?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|17|1|91-98

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.17, Iss.1, 2016-01, pp. : 91-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Future of Induced Pluripotent Stem Cells for Cardiac Therapy and Drug Development

By  

Current Pharmaceutical Design, Vol. 17, Iss. 30, 2011-10 ,pp. : 3258-3270

Bentham Science Publishers

Access to resources Recommend Favorite

Induced Pluripotent Stem Cells as a Model for Accelerated Patient- and Disease-specific Drug Discovery

By  

Current Medicinal Chemistry, Vol. 17, Iss. 8, 2010-03 ,pp. : 759-766

Bentham Science Publishers

Access to resources Recommend Favorite

Advances and applications of induced pluripotent stem cells

By Pietronave Stefano   Prat Maria  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 3, 2012-03 ,pp. : 317-325

NRC Research Press

Access to resources Recommend Favorite

Induced Pluripotent Stem Cells, New Tools for Drug Discovery and New Hope for Stem Cell Therapies

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 15-18

Bentham Science Publishers

Access to resources Recommend Favorite

Embryonic Stem Cells or Induced Pluripotent Stem Cells? A DNA Integrity Perspective

By  

Current Gene Therapy, Vol. 13, Iss. 2, 2013-04 ,pp. : 93-98

Bentham Science Publishers

Access to resources Recommend Favorite